P812: LONG-TERM COMPLEMENT INHIBITION AND SURVIVAL OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: AN INTERIM ANALYSIS OF THE RAVULIZUMAB CLINICAL TRIALS

Authors: A. Kulasekararaj, R. Brodsky, M. Griffin, A. Kulagin, M. Ogawa, J. Wang, A. Mujeebuddin, J.-I. Nishimura, R. Peffault de Latour, J. Szer, J. W. Lee

Published: 2022-06-23

DOI: 10.1097/01.hs9.0000846132.33920.32

Source: Full article

---

Abstract

No abstract found.